BioHealth News Archive
Top 10 M&A Deals of January–June 2019 – GEN – Genetic Engineering and Biotechnology News
Just one week into 2019, the new year got off to the proverbial roaring start for biopharma mergers and acquisitions (M&A) with the announcement…
Read More
Arlington Capital Partners Announces the Final Closing of Oversubscribed $1.7 Billion Fund
Arlington Capital Partners (“Arlington” or the “Firm”), a Washington, D.C. area based private equity investment firm focused on government-regulated sectors, today announced that it…
Read More
University of Maryland BioPark plans 10-story gateway tower on MLK Blvd. – Baltimore Sun
The University of Maryland, Baltimore plans an ambitious expansion of its BioPark, with a $200 million building that will nearly double the size of…
Read More
A CEO who wants to genetically modify pig organs for human transplant
Sometimes a Eureka moment sparks a breakthrough in innovation; other times it’s a rush to solve a crisis plaguing society — and the ones…
Read More
AstraZeneca’s immunotherapy drug scores key Phase III lung cancer win – MedCity News
The days of Roche having an immunotherapy monopoly on the largest population of small-cell lung cancer patients appear numbered, following the release of data…
Read More
Continuous Processing Requires a Rethink of Viral Strategies
If biopharma firms want to get the most out of continuous manufacturing, they must rethink their viral safety strategies. Existing strategies work well for…
Read More
Child healthcare reimagined in new ACE Kids Act care model
By Dr. Kurt Newman, CEO of Children’s National Health System We have come a long way in pediatric medicine, but not far enough. For…
Read More
Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities Nasdaq:NVAX
Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and Catalent Biologics’ Paragon Gene Therapy unit, the leading…
Read More
University of Maryland is first in the nation to launch degree in medical cannabis science – WJLA
The University of Maryland School of Pharmacy has launched the nation's first Master of Science program in medical cannabis science and therapeutics. The university…
Read More
MOST DYNAMIC METROPOLITANS – JUNE 2019
As the dominant economic geography of America, metropolitan statistical areas largely determine our success as a nation. These groups of counties with a large…
Read More
Adaptive Biotechnologies set to go public with valuation above $2B in biggest biotech IPO of 2019 – GeekWire
Adaptive Biotechnologies has raised the price for its initial public offering, putting itself in a position to raise more cash than any other biotech…
Read More
New Report: Health Tech Early Stage Deals Growing Again in First Quarter After Tepid 2018 – Inova Personalized Health Accelerator
Health Tech early stage (below $10 million) investing grew consistently from 2010 - 2017, but then stalled in 2018 showing declining deal count in…
Read More
AbbVie to buy Botox maker Allergan for $63B – MedCity News
The company that makes Botox is the subject of the latest biopharma mega-deal. Chicago-based AbbVie said Tuesday it would acquire Ireland-headquartered Allergan for $63…
Read More
Former Walter Reed Campus Undergoes Historic Renovation | Construction Equipment Guide
At the end of November in Washington, D.C., Children's National Health System began work on a historical renovation construction project that will result in…
Read More
PIC MC Selects Development Team to Build $40 Million Life Sciences Building on Montgomery College’s Germantown Campus – MC News
The Pinkney Innovation Complex for Science and Technology (PIC MC) signed a development agreement today to add a state-of-the-art life sciences office building to…
Read More